The clinical data of 371 HCC patients included patient age, gender, T stage, N stage, M stage, pathologic stage, histologic grade, fibrosis Ishak score, vascular invasion, tumor status, TP53 status (%), age, alpha-fetoprotein (AFP) (ng/ml), and prothrombin time (Table 1). This evidence concerns the gene TP53 and hepatocellular carcinoma.